BioPharma Credit (LON:BPCR – Get Free Report) insider Sapna Shah purchased 20,000 shares of BioPharma Credit stock in a transaction dated Wednesday, March 27th. The shares were acquired at an average cost of GBX 72 ($0.91) per share, with a total value of £14,400 ($18,197.90).
BioPharma Credit Trading Down 1.0 %
BPCR opened at GBX 0.87 ($0.01) on Friday. The company has a market capitalization of £11.31 million, a PE ratio of 6.69 and a beta of 0.21. BioPharma Credit has a 1-year low of GBX 0.81 ($0.01) and a 1-year high of GBX 0.98 ($0.01). The firm’s 50 day simple moving average is GBX 0.91 and its two-hundred day simple moving average is GBX 0.87.
BioPharma Credit Cuts Dividend
The business also recently declared a dividend, which will be paid on Tuesday, April 30th. Shareholders of record on Thursday, March 28th will be given a $0.02 dividend. This represents a yield of 1.97%. The ex-dividend date is Thursday, March 28th. BioPharma Credit’s payout ratio is 5,384.62%.
BioPharma Credit Company Profile
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.
See Also
- Five stocks we like better than BioPharma Credit
- How to invest in marijuana stocks in 7 steps
- 3 Value Stocks Too Small For Buffett’s Portfolio
- With Risk Tolerance, One Size Does Not Fit All
- Foot Locker Builds Up Another Head of Steam; Gains Imminent
- What are earnings reports?
- Disney Stock Catches 3 Upgrades In a Single Week
Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.
